Systemic and renal effects of nifedipine in cyclosporine-associated hypertension

Stephen C Textor, Lora Schwartz, Daniel J. Wilson, Russell Wiesner, Juan C. Romero, Jo Augustine, Paul Kos, Eileen Hay, Gregory James Gores, E. Rolland Dickson, Ruud A. Krom, Michael Porayko

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Cyclosporine induces hypertension and widespread vasoconstriction after transplantation in addition to reducing kidney function. We studied hemodynamic, renal, and hormonal effects of monotherapy with nifedipine XL (n=37) in liver transplant recipients within a year after transplant (median, 4.4 months). Systemic hemodynamics were determined with thoracic electrical bioimpedance. Blood pressure before therapy was 172±4/108±2 mm Hg. Sixty- four percent of recipients achieved blood pressures less than 140/90 mm Hg mediated by a fall in systemic vascular resistance index (2427±245 dyne · s · cm -5 · m -2 in responders versus 2905±281 in nonresponders, P<.01). Despite the fall in systemic vascular resistance, glomerular filtration rates were not changed during nifedipine therapy, as measured by both creatinine and iothalamate clearances. Urinary prostacyclin (6-ketoprostaglandin F(1α) was suppressed below normal from 2468±323 ng/d before transplant to 1103±99 ng/d (P<.01) after transplant and did not change during nifedipine therapy. Urinary thromboxane B 2 and plasma renin activity also fell after transplant and remained low during nifedipine. These data demonstrate that nifedipine can reverse systemic vasoconstriction associated with hypertension after transplantation. Systemic effects were not transmitted to the kidney sufficiently to improve glomerular filtration rate or reverse hormonal changes within the kidney. Hence, vascular and functional regulation of the kidney was dissociated from the systemic circulation during nifedipine administration after transplantation.

Original languageEnglish (US)
JournalHypertension
Volume23
Issue number1 SUPPL.
StatePublished - Jan 1994

Fingerprint

Nifedipine
Cyclosporine
Hypertension
Kidney
Transplants
Transplantation
Vasoconstriction
Glomerular Filtration Rate
Vascular Resistance
Hemodynamics
Iothalamic Acid
Blood Pressure
Thromboxanes
Epoprostenol
Renin
Blood Vessels
Creatinine
Thorax
Therapeutics
Liver

Keywords

  • calcium channel blockers
  • cyclosporine
  • epoprostenol
  • glomerular filtration rate
  • hemodynamics
  • nifedipine

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Textor, S. C., Schwartz, L., Wilson, D. J., Wiesner, R., Romero, J. C., Augustine, J., ... Porayko, M. (1994). Systemic and renal effects of nifedipine in cyclosporine-associated hypertension. Hypertension, 23(1 SUPPL.).

Systemic and renal effects of nifedipine in cyclosporine-associated hypertension. / Textor, Stephen C; Schwartz, Lora; Wilson, Daniel J.; Wiesner, Russell; Romero, Juan C.; Augustine, Jo; Kos, Paul; Hay, Eileen; Gores, Gregory James; Dickson, E. Rolland; Krom, Ruud A.; Porayko, Michael.

In: Hypertension, Vol. 23, No. 1 SUPPL., 01.1994.

Research output: Contribution to journalArticle

Textor, SC, Schwartz, L, Wilson, DJ, Wiesner, R, Romero, JC, Augustine, J, Kos, P, Hay, E, Gores, GJ, Dickson, ER, Krom, RA & Porayko, M 1994, 'Systemic and renal effects of nifedipine in cyclosporine-associated hypertension', Hypertension, vol. 23, no. 1 SUPPL..
Textor SC, Schwartz L, Wilson DJ, Wiesner R, Romero JC, Augustine J et al. Systemic and renal effects of nifedipine in cyclosporine-associated hypertension. Hypertension. 1994 Jan;23(1 SUPPL.).
Textor, Stephen C ; Schwartz, Lora ; Wilson, Daniel J. ; Wiesner, Russell ; Romero, Juan C. ; Augustine, Jo ; Kos, Paul ; Hay, Eileen ; Gores, Gregory James ; Dickson, E. Rolland ; Krom, Ruud A. ; Porayko, Michael. / Systemic and renal effects of nifedipine in cyclosporine-associated hypertension. In: Hypertension. 1994 ; Vol. 23, No. 1 SUPPL.
@article{c3252cd4385b437a94823e7f6ada043b,
title = "Systemic and renal effects of nifedipine in cyclosporine-associated hypertension",
abstract = "Cyclosporine induces hypertension and widespread vasoconstriction after transplantation in addition to reducing kidney function. We studied hemodynamic, renal, and hormonal effects of monotherapy with nifedipine XL (n=37) in liver transplant recipients within a year after transplant (median, 4.4 months). Systemic hemodynamics were determined with thoracic electrical bioimpedance. Blood pressure before therapy was 172±4/108±2 mm Hg. Sixty- four percent of recipients achieved blood pressures less than 140/90 mm Hg mediated by a fall in systemic vascular resistance index (2427±245 dyne · s · cm -5 · m -2 in responders versus 2905±281 in nonresponders, P<.01). Despite the fall in systemic vascular resistance, glomerular filtration rates were not changed during nifedipine therapy, as measured by both creatinine and iothalamate clearances. Urinary prostacyclin (6-ketoprostaglandin F(1α) was suppressed below normal from 2468±323 ng/d before transplant to 1103±99 ng/d (P<.01) after transplant and did not change during nifedipine therapy. Urinary thromboxane B 2 and plasma renin activity also fell after transplant and remained low during nifedipine. These data demonstrate that nifedipine can reverse systemic vasoconstriction associated with hypertension after transplantation. Systemic effects were not transmitted to the kidney sufficiently to improve glomerular filtration rate or reverse hormonal changes within the kidney. Hence, vascular and functional regulation of the kidney was dissociated from the systemic circulation during nifedipine administration after transplantation.",
keywords = "calcium channel blockers, cyclosporine, epoprostenol, glomerular filtration rate, hemodynamics, nifedipine",
author = "Textor, {Stephen C} and Lora Schwartz and Wilson, {Daniel J.} and Russell Wiesner and Romero, {Juan C.} and Jo Augustine and Paul Kos and Eileen Hay and Gores, {Gregory James} and Dickson, {E. Rolland} and Krom, {Ruud A.} and Michael Porayko",
year = "1994",
month = "1",
language = "English (US)",
volume = "23",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "1 SUPPL.",

}

TY - JOUR

T1 - Systemic and renal effects of nifedipine in cyclosporine-associated hypertension

AU - Textor, Stephen C

AU - Schwartz, Lora

AU - Wilson, Daniel J.

AU - Wiesner, Russell

AU - Romero, Juan C.

AU - Augustine, Jo

AU - Kos, Paul

AU - Hay, Eileen

AU - Gores, Gregory James

AU - Dickson, E. Rolland

AU - Krom, Ruud A.

AU - Porayko, Michael

PY - 1994/1

Y1 - 1994/1

N2 - Cyclosporine induces hypertension and widespread vasoconstriction after transplantation in addition to reducing kidney function. We studied hemodynamic, renal, and hormonal effects of monotherapy with nifedipine XL (n=37) in liver transplant recipients within a year after transplant (median, 4.4 months). Systemic hemodynamics were determined with thoracic electrical bioimpedance. Blood pressure before therapy was 172±4/108±2 mm Hg. Sixty- four percent of recipients achieved blood pressures less than 140/90 mm Hg mediated by a fall in systemic vascular resistance index (2427±245 dyne · s · cm -5 · m -2 in responders versus 2905±281 in nonresponders, P<.01). Despite the fall in systemic vascular resistance, glomerular filtration rates were not changed during nifedipine therapy, as measured by both creatinine and iothalamate clearances. Urinary prostacyclin (6-ketoprostaglandin F(1α) was suppressed below normal from 2468±323 ng/d before transplant to 1103±99 ng/d (P<.01) after transplant and did not change during nifedipine therapy. Urinary thromboxane B 2 and plasma renin activity also fell after transplant and remained low during nifedipine. These data demonstrate that nifedipine can reverse systemic vasoconstriction associated with hypertension after transplantation. Systemic effects were not transmitted to the kidney sufficiently to improve glomerular filtration rate or reverse hormonal changes within the kidney. Hence, vascular and functional regulation of the kidney was dissociated from the systemic circulation during nifedipine administration after transplantation.

AB - Cyclosporine induces hypertension and widespread vasoconstriction after transplantation in addition to reducing kidney function. We studied hemodynamic, renal, and hormonal effects of monotherapy with nifedipine XL (n=37) in liver transplant recipients within a year after transplant (median, 4.4 months). Systemic hemodynamics were determined with thoracic electrical bioimpedance. Blood pressure before therapy was 172±4/108±2 mm Hg. Sixty- four percent of recipients achieved blood pressures less than 140/90 mm Hg mediated by a fall in systemic vascular resistance index (2427±245 dyne · s · cm -5 · m -2 in responders versus 2905±281 in nonresponders, P<.01). Despite the fall in systemic vascular resistance, glomerular filtration rates were not changed during nifedipine therapy, as measured by both creatinine and iothalamate clearances. Urinary prostacyclin (6-ketoprostaglandin F(1α) was suppressed below normal from 2468±323 ng/d before transplant to 1103±99 ng/d (P<.01) after transplant and did not change during nifedipine therapy. Urinary thromboxane B 2 and plasma renin activity also fell after transplant and remained low during nifedipine. These data demonstrate that nifedipine can reverse systemic vasoconstriction associated with hypertension after transplantation. Systemic effects were not transmitted to the kidney sufficiently to improve glomerular filtration rate or reverse hormonal changes within the kidney. Hence, vascular and functional regulation of the kidney was dissociated from the systemic circulation during nifedipine administration after transplantation.

KW - calcium channel blockers

KW - cyclosporine

KW - epoprostenol

KW - glomerular filtration rate

KW - hemodynamics

KW - nifedipine

UR - http://www.scopus.com/inward/record.url?scp=0027952646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027952646&partnerID=8YFLogxK

M3 - Article

C2 - 8282363

AN - SCOPUS:0027952646

VL - 23

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 1 SUPPL.

ER -